Akshar Gamma Steriles Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.43 Cr
- Revenue Growth %
- Total Assets 22.31%
About Akshar Gamma Steriles Llp
Akshar Gamma Steriles Llp (AGSL) is 6 Year, 1 Month old Limited Liability Partnership 08 January 2019. Its registered office is in Thane, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN/FCRN
AAN-9504
- Incorporation Date
08 Jan 2019
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Akshar Gamma Steriles Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarita Lakhani  | Designated Partner | 08-Jan-2019 | Current |
| Ramesh Lakhani | Designated Partner | 08-Jan-2019 | Current |
| Gaurang Lakhani | Designated Partner | 08-Jan-2019 | Current |
Financial Performance of Akshar Gamma Steriles Llp.
Akshar Gamma Steriles Llp, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Akshar Gamma Steriles Llp?
Unlock access to Akshar Gamma Steriles Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹224.30 M
₹0
Charges Breakdown by Lending Institutions
- Dombivli Nagari Sahakari Bank Ltd (Dnsb) Lead And Member Jankalyan Sahakari Bank Ltd (Jksb) : 16.46 Cr
- Dombivli Nagari Sahakari Bank Limited : 5.97 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2023 | Dombivli Nagari Sahakari Bank Limited | ₹3.27 Cr | Open |
| 03 Apr 2022 | Dombivli Nagari Sahakari Bank Limited | ₹2.70 Cr | Open |
| 17 Dec 2019 | Dombivli Nagari Sahakari Bank Ltd (Dnsb) Lead And Member Jankalyan Sahakari Bank Ltd (Jksb) | ₹16.46 Cr | Open |
How Many Employees Work at Akshar Gamma Steriles Llp?
Unlock and access historical data on people associated with Akshar Gamma Steriles Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshar Gamma Steriles Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshar Gamma Steriles Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.